Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changfu Xiao

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Pharmaceutical Statistics|July 30, 2013
Dose finding when the target dose is on a plateau of a dose-response curve: comparison of fully sequential designsAnastasia Ivanova, Changfu Xiao
Journal of Statistical Planning and Inference|June 20, 2012
Adaptive Isotonic Estimation of the Minimum Effective and Peak Doses in the Presence of CovariatesChangfu Xiao, Anastasia Ivanova
Statistics in Medicine|August 7, 2012
Two-stage designs for Phase 2 dose-finding trialsAnastasia Ivanova, Changfu Xiao, Yevgen Tymofyeyev
Frontiers in Neurology|February 8, 2021
Estimating Burden of Disease Among Blind Individuals With Non-24-Hour Sleep-Wake DisorderLauren Van Draanen, Changfu Xiao, Mihael H Polymeropoulos
Journal of Alternative and Complementary Medicine (New York, N.Y.)|April 9, 2016
Self-Management of Arthritis Symptoms by Complementary and Alternative Medicine Movement TherapiesThelma J Mielenz, Changfu Xiao, Leigh F Callahan
Plos One|September 19, 2025
Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trialNaoise C Synnott, Christos M Polymeropoulos, Changfu Xiao, et al.
Journal of Global Antimicrobial Resistance|July 17, 2021
Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibilitySandra P Smieszek, Vasilios M Polymeropoulos, Changfu Xiao, et al.
Journal of Sleep Research|June 21, 2021
Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteonRosarelis Torres, Michaela Fisher, Gunther Birznieks, et al.
Clinical and Translational Gastroenterology|March 17, 2022
Enrichment of Motilin Receptor Loss-of-Function Variants in GastroparesisSandra P Smieszek, Jesse L Carlin, Changfu Xiao, et al.
Plos One|January 5, 2023
Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sicknessMark É Czeisler, Justina M Pruski, Pan Wang, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Pharmaceutical Statistics|July 30, 2013
Dose finding when the target dose is on a plateau of a dose-response curve: comparison of fully sequential designsAnastasia Ivanova, Changfu Xiao
Journal of Statistical Planning and Inference|June 20, 2012
Adaptive Isotonic Estimation of the Minimum Effective and Peak Doses in the Presence of CovariatesChangfu Xiao, Anastasia Ivanova
Statistics in Medicine|August 7, 2012
Two-stage designs for Phase 2 dose-finding trialsAnastasia Ivanova, Changfu Xiao, Yevgen Tymofyeyev
Frontiers in Neurology|February 8, 2021
Estimating Burden of Disease Among Blind Individuals With Non-24-Hour Sleep-Wake DisorderLauren Van Draanen, Changfu Xiao, Mihael H Polymeropoulos
Journal of Alternative and Complementary Medicine (New York, N.Y.)|April 9, 2016
Self-Management of Arthritis Symptoms by Complementary and Alternative Medicine Movement TherapiesThelma J Mielenz, Changfu Xiao, Leigh F Callahan
Plos One|September 19, 2025
Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trialNaoise C Synnott, Christos M Polymeropoulos, Changfu Xiao, et al.
Journal of Global Antimicrobial Resistance|July 17, 2021
Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibilitySandra P Smieszek, Vasilios M Polymeropoulos, Changfu Xiao, et al.
Journal of Sleep Research|June 21, 2021
Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteonRosarelis Torres, Michaela Fisher, Gunther Birznieks, et al.
Clinical and Translational Gastroenterology|March 17, 2022
Enrichment of Motilin Receptor Loss-of-Function Variants in GastroparesisSandra P Smieszek, Jesse L Carlin, Changfu Xiao, et al.
Plos One|January 5, 2023
Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sicknessMark É Czeisler, Justina M Pruski, Pan Wang, et al.
Pageof 3